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Abstract
Apoptosis may represent a prominent form of neuronal death in chronic neurodegenerative disorders, such as Alzheimer’s disease.
Although apoptosis under mitochondrial control has received considerable attention, mechanisms used within the endoplasmic reticulum
(ER) and nucleus in mediating apoptotic signals are not well understood. A growing body of evidence is emerging from different studies
which suggests an active role for the ER in regulating apoptosis. Disturbances of ER function have been shown to trigger two different
apoptotic pathways; one involves cross-talk with mitochondria and is regulated by the antiapoptotic Bcl-2, and the second is characterized
by the activation of caspase-12. Also, stress in the ER has been suggested to result in the activation of a number of proteins, such as gadd
153 and NF-k, and in the downregulation of the antiapoptotic protein, Bcl-2. In the present study, the intracisternal injection in aged
rabbits of either the neurotoxin aluminum maltolate or of Ab(1-42), has been found to induce nuclear translocation of gadd 153 and the
inducible transcription factor, NF-kB. Translocation of these two proteins is accompanied by decreased levels of Bcl-2 in both the ER and
the nucleus. Aluminum maltolate, but not Ab, induces caspase-12 activation which is a mediator of ER-specific apoptosis; this is the first
report of the in vivo activation of caspase-12. These findings indicate that the ER may play a role in regulating apoptosis in vivo, and
could be of significance in the pathology of neurodegeneration and related disorders.  2001 Elsevier Science B.V. All rights reserved.
Theme: Disorders of the nervous system
Topic: Neurotoxicity
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1. Introduction
Evidence is accumulating that apoptotic cell death is a
major factor in human neurodegenerative disorders, including Alzheimer’s disease, and that this event may precede
the formation of intraneuronal neurofibrillary tangles and
neuritic plaques [38]. Although mitochondrial alterations
may represent an important step in the mechanisms
underlying this neuronal cell death, mitochondria may not
*Corresponding author. Tel.: 11-804-924-5682; fax: 11-804-9245718.
E-mail address: js2r@virginia.edu (J. Savory).

be the only cellular organelle which control neuronal loss
in neurodegeneration. There is now evidence suggesting
that the endoplasmic reticulum (ER) also may play an
important role in regulating neuronal cell death, thereby
raising the question of whether the cell death pathway in
neurodegenerative disorders is triggered by mitochondria
or by the ER [29,37]. However, studies of involvement of
the ER in neuronal death have lagged behind those of
mitochondria, and the role of the ER in the pathogenesis of
neurodegenerative disorders should be considered. Indeed,
in addition to its physiological role as a calcium and
protein store, the ER is the site of localization for the
presenilin-1 mutation which has been linked to the early
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onset of familial Alzheimer’s disease [1]. The ER has also
been identified as the site of formation of the peptide
Ab(1-42), which may be the earliest event to take place in
Alzheimer’s disease [11]. In addition, ER stress-inducing
agents have been shown to activate the expression of
various genes, such as those coding for the gene gadd 153,
important in growth arrest and DNA damage-induction
[30], and the inducible transcription factor, NF-kB [4,36].
Several lines of evidence suggest that NF-kB plays an
important role in the survival of neurons by its translocation from the cytoplasm into the nucleus [3,24,27]. Moreover, members of the Bcl-2 family of proteins, Bcl-2 and
Bcl-X L , reside in the ER, and it has been established that
they are also important in determining cellular and neurological outcomes in neurodegenerative disorders (for review, see Ref. [8]). Recently, stress in the ER has been
shown to result in a specific type of apoptosis, independent
of mitochondrial-targeted apoptotic signals; this novel
pathway is mediated by caspase-12 [23]. Procaspase-12
resides in the ER, and upon its activation by ER stress, is
released into the cytoplasm in an active form (caspase-12),
thus initiating apoptosis.
Previous studies in our laboratory have used the neurotoxin, aluminum (Al) maltolate, injected into rabbit brain
as a means for investigating the mechanisms of neurodegeneration, since this system demonstrates cytoskeletal
changes that share a number of biochemical similarities
with those found in Alzheimer’s disease [12,33]. Having
observed these results with the highly neurotoxic Al
maltolate, we now extend our studies to Ab, which also
has been demonstrated to be neurotoxic and is now
considered to play a central role in the pathogenesis of
Alzheimer’s disease, a hypothesis supported by genetic,
biochemical, histopathological and animal modeling data
[35]. In the present experiments, carried out on aged male
New Zealand White rabbits, we have examined Al maltolate-induced stress in the ER, as assessed by the activation of gadd 153 and its translocation into the nucleus, and
have compared the results to changes produced by the
administration of Ab(1-42). We have also examined the
effect of these two treatment regimens on caspase-12
activation, Bcl-2 protein levels in ER and in the nuclear
fractions, and on NF-kB translocation. Since the hippocampus is frequently involved in Alzheimer’s disease,
we have focused our studies on this area of the brain.

2. Materials and methods

2.1. Materials
Ab(1-42) was obtained from American Peptide Company (Sunnyvale, CA). Mouse monoclonal antibody (mAb)
specific to human gadd 153 (B-3), Bcl-2 (C-2), and
NF-kB (C-5), were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Caspase-12 mAb was a gift from Dr
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Junying Yuan, Harvard Medical School, Boston, MA; bactin and a-mouse IgG FITC were obtained from Sigma
(St Louis, MO); and Cy3-conjugated goat anti-mouse IgG
from Jackson ImmunoResearch Laboratories (West Grove,
PA).

2.2. Animals, treatment protocol and tissue collection
All animal procedures were carried out in accordance
with the U.S. Public Health Service Policy on the Humane
Care and Use of Laboratory Animals, and the National
Institutes of Health Guide for the Care and Use of
Laboratory Animals. The animal protocol was approved by
the University of Virginia Animal Care and Use Committee. Aged (4.5–5 years old) male New Zealand White
rabbits received either intracisternal injections of 100 ml
normal saline (n55; controls), 100 ml of 25 mM Al
maltolate in saline (n56; Al-treated group), or 100 ml of 1
mg / ml Ab(1-42) in saline (n57; Ab-treated group).
Aggregate Ab(1-42) was prepared by incubating freshly
solubilized Ab(1-42) at a concentration of 1 mg / ml in
saline at 378C for 3 days. The injections were carried out
under ketamine anesthesia as described previously [34].
All rabbits were euthanized after 15 days, at which time
the Al-treated animals had developed severe neurological
symptoms, requiring their sacrifice, including forward head
tilt, hemiplegic gait, loss of appetite, splaying of the
extremities and paralysis. The controls and Ab(1-42)
animals did not display clinical symptoms. At the time of
sacrifice the rabbits were perfused with Dulbecco’s phosphate buffered saline (Gibco, Grand Island, NY), also as
described previously [34]. Brains were immediately removed, and a coronal section cut and bisected to yield two
symmetrical hippocampal segments, one for immunohistochemistry and the other for immunoblot analysis. Each
brain hemisphere intended for histochemistry was immediately frozen rapidly on a liquid nitrogen-cooled surface,
placed into a zipper-closure plastic bag, and buried in dry
ice pellets until transfer to 2808C for storage before
sectioning. For immunoblot analysis, tissue from the
hippocampus was rapidly dissected, homogenized and
processed as described below.

2.3. Western blot analysis
Proteins from the subcellular fractions were extracted as
described previously [19]. Approximately 50 mg of brain
tissue from hippocampus was gently homogenized, using a
Teflon homogenizer (Thomas, Philadelphia, PA), in seven
volumes of cold suspension buffer (20 mM Hepes–KOH
(pH 7.5), 250 mM sucrose, 10 mM KCl, 1.5 mM MgCl 2 , 1
mM EDTA, 1 mM EGTA, 1 mM DTT, 0.1 mM PMSF, 2
mg / ml aprotinin, 10 mg / ml leupeptin, 5 mg / ml pepstatin
and 12.5 mg / ml of N-acetyl-Leu-Leu-Norleu-Al). The
homogenates were centrifuged at 9003g at 48C for 10 min
to isolate the nuclear fraction, and then at 80003g for 20

32

O. Ghribi et al. / Molecular Brain Research 96 (2001) 30 – 38

min at 48C to separate the mitochondrial fraction from the
soluble fraction. The supernatant was further centrifuged at
100 0003g for 60 min at 48C to separate the cytoplasmic
from the ER fractions. We examined changes of proteins in
the subcellular fractions where they are reported to be
localized and / or translocated; gadd 153 and NF-kB in the
cytoplasmic and nuclear fractions, Bcl-2 in the endoplasmic reticulum and nuclear fractions, and caspase-12 in
cytoplasmic fractions. Protein concentrations were determined with the BCA protein assay reagent (Pierce, Rockford, IL). Proteins (7.5 mg) were separated by SDS–PAGE
(15% gel) under reducing conditions, followed by transfer
to a polyvinylidene difluoride membrane (Millipore, Bedford, MD) at 300 mA for 210 min in transfer buffer (20
mM Tris-base, 150 mM glycine, 20% methanol). Following transfer, membranes were incubated overnight at 48C
with mouse mAb to human gadd 153 and NF-kB at a
1:250 dilution, caspase-12 at 1:10, and Bcl-2 at 1:100.
b-Actin was used at a 1:500 dilution as a gel-loading
control. The blots were developed with enhanced chemiluminescence (Immun-Star detection kit, Bio-Rad, Hercules, CA). The bands of gadd 153, caspase-12, Bcl-2 and
NF-kB were scanned and densitometrically analyzed using
Personal Densitometer SI and Image Quant 5.0 software
(Molecular Dynamics, Sunnyvale, CA), and these quantitative analyses were expressed as mean6S.E.M. values. The
unpaired Student’s t-test was used to compare levels of
each protein between the controls and Al-treated or Ab(142)-treated animals in the same subcellular fraction.

2.4. Immunohistochemistry
Serial 14-mm-thick coronal frozen sections from control,
Al-treated, and Ab(1-42)-treated animals were cut at the
level of the mid-hippocampus and stored under dessicant at
2808C prior to immunostaining. The sections were airdried at room temperature, fixed in cold acetone for 10
min, treated with 1% hydrogen peroxide in PBS and
incubated with a blocking solution of 1.5% normal serum,
also in PBS. Subsequently, sections were reacted overnight
at 48C with a mouse mAb at a 1:250 dilution against gadd
153 or NF-kB. After washing with 50 mM TBS and
incubating with the biotinylated secondary antibody, sections were processed with a Vectastain Elite Avidin–Biotin
complex technique kit (Vector Laboratories, Burlingame,
CA). Immunostaining for gadd 153 was visualized by the
use of Vector SG substrate and counterstained with a
Nuclear Fast Red counterstain kit (Vector Laboratories,
Burlingame, CA). Sections incubated with NF-kB antibody
were visualized with DAB Chromogen (Dako Corporation,
Carpinteria, CA) and counterstained with methyl green
(Sigma, St Louis, MO). For negative controls, using
similar sections, normal saline was substituted for the
monoclonal antibody.
For double labeling of NF-kB and gadd 153, frozen
coronal brain sections (14 mm thick) from the hippocampal

level of controls, Al-treated and Ab(1-42)-treated animals
were dried for 15 min at room temperature (RT) and fixed
in 10% formalin for 15 min, followed by a 10 min
incubation in 1:2 vol / vol ethanol / acetic acid. Sections
were washed three times in PBS for 5 min each and
permeabilised with 0.3% Triton X-100 for 20 min at RT.
Sections were then washed three times in PBS buffer for 5
min each, blocked with 2% goat serum and incubated for 2
h at 378C in a 1:200 dilution of the gadd 153 mouse mAb.
Sections were then washed three times in PBS for 5 min
and incubated for 2 h at 378C in a 1:500 dilution of the
Cy3-conjugated goat anti-mouse IgG. Sections were
washed in PBS buffer and then in distilled H 2 O, blocked
with 2% goat serum and incubated for 2 h at 378C in a
1:250 dilution of NF-kB mouse mAb, then incubated for 2
h at 378C in a 1:250 dilution of a-mouse IgG FITC. After
335 min washes in PBS and a 5-min wash in distilled
H 2 O, sections were coverslipped and examined with a
fluorescence Olympus BH2 microscope (Melville, NY),
using Image Pro Plus 4.1 analysis software (Media Cybernetics, Baltimore, MD).

3. Results

3.1. Western blot analysis
As shown in Fig. 1A and Table 1, gadd 153 (|30 kDa)
is found only in the cytoplasmic fraction in control
animals, but is present in the cytoplasmic and nuclear
fractions in the Al- and Ab(1-42)-treated groups. Caspase12 (|60 kDa) is detected in the cytoplasmic fractions from
Al-treated rabbits but is not expressed in the cytoplasmic
fractions from controls (Fig. 1B and Table 1). A very faint
band corresponding to caspase-12 is seen in the Ab-treated
animals (Fig. 1B), but its significance is not conclusive.
Bcl-2 can be identified by a protein band having an
apparent molecular weight of 27 kDa, both in the ER and
nuclear fractions in controls (Fig. 1C). In comparison to
these control animals, Al maltolate and Ab(1-42) administration induce a decrease in Bcl-2 levels, both in the ER
and nuclear fractions (Fig. 1C and Table 1). Two bands are
detected for NF-kB (Fig. 1D), corresponding to p52 and
p100; these are observed only in the cytoplasmic fraction
of controls, with no bands being detected in the nuclear
fraction. In the Al maltolate and Ab(1-42)-treated animals,
the two bands corresponding to p52 and p100 are also
detected in the cytoplasmic fractions; in these animals
there is an intense band in the nuclear fraction, corresponding to p52, and a lighter band for p100 (Table 1).

3.2. Immunohistochemistry
The immunohistochemical localization of NF-kB and
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Fig. 1. Western blot of gadd 153 (A), caspase-12 (B), Bcl-2 (C) and NF-kB (D), in cytoplasmic (c), nuclear (n), or endoplasmic reticulum (er), fractions
from controls (1), and Al-treated (2) or Ab(1-42)-treated (3) animals. (A) In controls (1), gadd 153 is detected in the cytoplasmic, but not in the nuclear,
fraction. Following Al (2) or Ab(1-42) (3) administration, gadd 153 is present in the cytoplasmic fractions and also in the nuclear fractions. (B)
Caspase-12 is expressed only in the cytoplasmic fraction of Al-treated animal (2), and not in control (1) or Ab(1-42)-treated (3) animals. (C) Bcl-2
staining is intense in both the endoplasmic reticulum and nuclear fractions from controls (1). The staining for Bcl-2 is strongly reduced in both the
endoplasmic reticulum and nucleus with Al (2) or Ab (3). (D) In the cytoplasmic fraction of controls (1), NF-kB is present as a dimer, the two bands
corresponding to p52 and p100. Following Al (2) or Ab(1-42) (3) administration, respectively, p52 and p100 are detectable in the cytoplasmic fractions; in
the nuclear fraction, while p100 is barely detectable, p52 is present in abundance.

Table 1
Densitometric analysis of gadd 153, caspase-12, Bcl-2, and NF-kB blots in control (n55), Al-treated (n56), and Ab(1-42) (n57)-treated rabbits
Cytoplasm
gadd 153

Controls
Aluminium
A-b(1-42)

3.1760.23
2.9860.33
2.8560.11

Caspase-12

Controls
Aluminium
A-b(1-42)

–
1.1260.12
6

Bcl-2

Controls
Aluminium
A-b(1-42)

NF-kB

Controls
Aluminium
A-b(1-42)

ER

–
1.6060.18
1.7560.16

2.5060.11
0.8260.17**
0.9160.18**
p52
1.6160.22
1.7860.10
1.6660.18

Nucleus

p100
1.4860.22
1.8860.13
1.6060.18

–, undetectable levels; 6, barely detectable; empty columns, not measured.
**P,0.01 (Student’s t-test, in comparison to controls).

2.2960.22
0.7560.12**
0.7860.26**
p52
–
0.6660.11
0.7260.13

p100
–
0.2460.09
0.1660.08
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gadd 153 in the pyramidal cell layer of the hippocampus
(CA1) of all animals has been examined (Fig. 2A).
In sections from control rabbits, no staining for NF-kB

is present (Fig. 2B) but minimal cytoplasmic staining for
gadd 153 is noted (Fig. 2C). However, in sections from
Al-treated (Fig. 2D,F) and Ab(1-42)-treated animals (Fig.

Fig. 2. Photomicrographs of labeling in the CA1 pyramidal cell layer of the hippocampus (A) for NF-kB (B, D and E) and gadd 153 (C, F and G) in
controls, Al-treated and Ab(1-42)-treated animals. Control sections are immunostained with NF-kB (B) or gadd 153 (C) and demonstrate negativity for
NF-kB but scanty cytoplasmic positivity for gadd 153. Positive (brown-black) reactivity for NF-kB is found in the nucleus in sections from Al-treated (D)
or Ab(1-42)-treated (E) animals (methyl green nuclear counterstain), with some cytoplasmic positivity in both. gadd 153 antibody also demonstrates
nuclear positivity (deep-purple staining) in Al-treated (F) and Ab(1-42)-treated (G) animals (nuclear fast red counterstain), with lesser cytoplasmic staining
in both groups. Insets in B–G are of cells at higher magnification but from their respective low magnification fields. Scale bars: in B–G, 50 mm; in B–G
insets, 10 mm.
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2E,G), enhanced positive immunostaining for gadd 153
(brown-black reaction product) and NF-kB (purple reaction product) are found in association with the nuclei of
most neurons, as well as variable cytoplasmic positivity.
Using fluorescent microscopy, sections from control
animals labeled for NF-kB (Fig. 3A) and gadd 153 (Fig.
3B) and colabelled for both proteins (Fig. 3C) demonstrate
a very few scattered, labelled neurons in the pyramidal
layer (CA1) of the hippocampus, while Al maltolate
administration induces numerous NF-kB-positive (Fig.
3D) and gadd 153 -positive (Fig. 3E) neurons in the same
region. As shown in Fig. 3F, NF-kB is occasionally
colocalized with gadd 153. Treatment with A-b(1-42) also
induces fluorescent labelling for both NF-kB (Fig. 3G) and
gadd 153 (Fig. 3H) and, as with Al maltolate treatment,
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several neurons exhibit both NF-kB and gadd 153 positivity (Fig. 3I).

4. Discussion
Disturbances of ER function have been shown to trigger
different apoptotic pathways. The first involves cross-talk
between the ER and mitochondria, and is regulated by the
antiapoptotic protein, Bcl-2 [10]. A second pathway,
distinct from that involving mitochondria, has recently
been demonstrated and involves activation of caspase-12
[22,23]. In these studies, it has been shown in mouse
cortical neurons that Ab(1-40) triggers an ER-specific
apoptosis mediated by active caspase-12, and that a

Fig. 3. Immunofluorescence images of NF-kB (green) and gadd 153 (red) labeling in the hippocampal CA1 area of control (top column), Al-treated
(middle column), and Ab(1-42)-treated (lower column) animals; columns proceed left to right. NF-kB (A) and gadd 153 (B) demonstrate labeling in
controls; (C) is an overlay of (A) and (B). NF-kB labeling shows more numerous immunopositive cells following Al administration (D) or following
Ab(1-42)-treatment (G), compared to the sparsely-positive cells in the control (A). Gadd 153 immunoreactivity is also greatly increased in neurons from
an Al-treated (E) or Ab(1-42)-treated animal (H) compared to a control (B). (F) Image overlay of (D) and (E), showing co-localization of positive NF-kB
labeling with gadd 153 in an Al-treated animal. (I) Image overlay of (G) and (H) demonstrates a number of positive neurons double-labelled (arrows) with
NF-kB and gadd 153 in an Ab(1-42)-treated animal. Scale bars represent 20 mm.
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reduction in caspase-12 provides protection from apoptosis. The authors suggest that cleavage of procaspase-12
(which resides in the ER) to active cytoplasmic caspase-12
is accomplished by a cysteine family member, m-calpain
[22]. In addition, factors that induce ER stress activate the
expression of various genes that code for ER resident
proteins; examples include gadd 153 [30] and activation of
the inducible transcription factor, NF-kB [26]. Activation
of gadd 153 or NF-kB leads to their translocation into the
nucleus, where they may play a role in neuronal survival or
death. It has been demonstrated that the gadd 153 gene is
specifically activated by agents that disturb ER function.
mRNA levels for gadd 153 are increased, both during
hypoxia and after exposure of cells to agents that elevate
the levels of glucose-regulated proteins [31]. Activation of
gadd 153 expression has also been confirmed following
transient cerebral ischemia in the rat [30]. Furthermore, the
magnitude of gadd 153 expression appears to be proportional to the extent of damage, as in homocysteine-induced
death in neuronal cell cultures [2].
In the present report, we show that both Al and Ab(142) induce stress in the ER, as demonstrated by the
activation of gadd 153 and its translocation into the
nucleus, which we have confirmed both by immunohistochemistry and Western blot analysis. We also report for the
first time the in vivo activation of caspase-12; this is
clearly seen following Al treatment, but is inconclusive
when we administer Ab(1-42).
Bcl-2 possesses an antiapoptotic function and is located
in membranes of the mitochondria, ER, and nucleus of
different cell types (for review, see Ref. [6]). Overexpression of Bcl-2 has been demonstrated to prevent the efflux
of cytochrome c from the mitochondria and the subsequent
initiation of apoptosis in staurosporine-treated cells [39]; it
prolongs the life of neurons in rats subjected to ischemia
[5] or in a transgenic mouse model of familial amyotrophic
lateral sclerosis [16]. Bcl-2 targeted to the endoplasmic
reticulum has been shown to block certain types of
apoptosis [18,40]. We have recently demonstrated that in
mitochondrial and ER fractions derived from brain, levels
of Bcl-2 are decreased following Al maltolate administration to young adult rabbits [7]. Recent reports have shown
that neuronal apoptosis induced by the Alzheimer’s disease
Ab peptide is related to an alteration of the proapoptotic
Bax / antiapoptotic Bcl-2 ratio [28], and that transgenic
murine cortical neurons expressing human Bcl-2 exhibit
increased resistance to Ab(1-42) [32]. Treatment of primary cultures of human neurons with Ab(1-40) provokes a
down-regulation of Bcl-2 expression [28]. In the present
experiments, we have measured levels of Bcl-2 protein in
the ER and in the nucleus, and our results show that
treatment with either Al or Ab(1-42) induces a marked
decrease in Bcl-2 levels in both organelles.
The inducible transcription factor, NF-kB, is an important mediator of the human immune and inflammatory
response [3]. Exposure of cells to various pathological

stimuli activates NF-kB; activated NF-kB dimer is rapidly
released from the cytoplasm, where it is normally sequestered by the inhibitory unit IkB, and then translocates
to the nucleus, where it activates transcription of different
genes (for a review, see Ref. [26]). Various agents that
induce stress in the ER have been shown to activate
NF-kB [9,25,27]. The role of NF-kB in regulating neuronal death is complex. In some cases it has been demonstrated to promote neuronal survival, and in other cases to
promote neuronal death. NF-kB, activated by low doses of
Ab(1-40), has been shown to be neuroprotective in
cerebellar granule cells [15]. NF-kB has also been reported
to be involved in the survival of cerebellar granule neurons
subjected to different potassium concentrations [17]. In
global ischemia and traumatic spinal cord injury, however,
NF-kB promotes neuronal death (for review, see Ref.
[20]). Moreover, increased levels of NF-kB activity have
been observed in the brain of patients with various
neurodegenerative disorders, including Alzheimer’s disease [14], Parkinson’s disease [13], and amyotrophic
lateral sclerosis [21]. Thus, it appears that whether NF-kB
acts as a promoter or inhibitor of neuronal loss depends on
the cell type and the nature of the toxic stimuli. In our
study, we demonstrate that NF-kB is activated in response
to the administration of either Al or Ab (1-42). Whether
the translocation of NF-kB into the nucleus represents a
cellular defensive mechanism, or represents an event
facilitating neuronal injury remains unclear.
In summary, our data show that both Al maltolate and
Ab(1-42) induce stress in the ER of rabbit brain. In
response to the induced stress, the ER-resident protein,
gadd 153, and the inducible transcriptional factor, NF-kB,
are both translocated into the nucleus. Furthermore, Aland Ab(1-42)-induced stress is also accompanied by a
decrease in the antiapoptotic protein, Bcl-2, both in the ER
and in the nucleus. In addition, Al activates caspase-12, a
process specific to the ER-mediated apoptosis pathway. We
propose that, although mitochondrial apoptotic signals are
important in regulating apoptosis, the ER and nuclear
organelles may also participate in the molecular mechanisms of apoptosis following neurotoxic stimuli.
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